Glycolic AcidvsResveratrol

Glycolic acid disrupts ionic bonds between corneocytes (dead skin cells) in the stratum corneum by chelating calcium ions and lowering the calcium concentration at desmosomal junctions. This weakens corneodesmosome integrity and activates endogenous proteases (kallikrein 5 and 7), accelerating desquamation. At higher concentrations, glycolic acid penetrates the viable epidermis and dermis, where it stimulates keratinocyte differentiation and upregulates transforming growth factor-beta (TGF-β) signaling in fibroblasts. This promotes glycosaminoglycan (GAG) synthesis, type I and III collagen production via procollagen gene expression, and elastin remodeling. Its small molecular size (76 Da) and high water solubility give it the deepest penetration of any AHA. The exfoliation also improves barrier function over time by promoting proper corneocyte maturation and reducing stratum corneum compaction.

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.